490 related articles for article (PubMed ID: 17682981)
21. Schistosomiasis does not contribute to death or recurrence of nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected Malawian adults.
Gordon MA; Zijlstra EE; Naus CW; Visser LG; Molyneux ME; van Lieshout L
Clin Infect Dis; 2003 Dec; 37(12):e177-9. PubMed ID: 14689364
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
Tompkins JC; Witzig RS
Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
[TBL] [Abstract][Full Text] [Related]
23. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
24. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG; Karstaedt AS
Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
[TBL] [Abstract][Full Text] [Related]
25. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A
Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452
[TBL] [Abstract][Full Text] [Related]
26. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of antiretroviral multiclass resistance.
Lima VD; Harrigan PR; Sénécal M; Yip B; Druyts E; Hogg RS; Montaner JS
Am J Epidemiol; 2010 Aug; 172(4):460-8. PubMed ID: 20667931
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
[TBL] [Abstract][Full Text] [Related]
29. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
30. Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France.
Lagrange-Xélot M; Porcher R; Sarfati C; de Castro N; Carel O; Magnier JD; Delcey V; Molina JM
HIV Med; 2008 Feb; 9(2):126-30. PubMed ID: 18257775
[TBL] [Abstract][Full Text] [Related]
31. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era.
Kramer JR; Giordano TP; Souchek J; El-Serag HB
J Hepatol; 2005 Mar; 42(3):309-14. PubMed ID: 15710213
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.
Abgrall S; Rabaud C; Costagliola D;
Clin Infect Dis; 2001 Nov; 33(10):1747-55. PubMed ID: 11595976
[TBL] [Abstract][Full Text] [Related]
34. The oncology impact of highly active antiretroviral therapy.
Schlichemeyer R; Chambers C; Gill MJ
J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
[TBL] [Abstract][Full Text] [Related]
35. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
Kosmas N; Kontos A; Panayiotakopoulos G; Dimitrakopoulos A; Kordossis T
J Med Virol; 2006 Oct; 78(10):1257-61. PubMed ID: 16927287
[TBL] [Abstract][Full Text] [Related]
36. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
37. Extraintestinal focal infections in adults with nontyphoid Salmonella bacteraemia: predisposing factors and clinical outcome.
Chen PL; Chang CM; Wu CJ; Ko NY; Lee NY; Lee HC; Shih HI; Lee CC; Wang RR; Ko WC
J Intern Med; 2007 Jan; 261(1):91-100. PubMed ID: 17222172
[TBL] [Abstract][Full Text] [Related]
38. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
39. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
[TBL] [Abstract][Full Text] [Related]
40. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
